Neuralgia

Neuralgia is associated in the literature with lesions or disease of the central or peripheral somatosensory nervous system. Reported sources of neuropathic pain include nerve compression, channelopathies, autoimmune disease, incision, and diabetic neuropathy as a frequent cause of peripheral neuropathic pain.

The literature describes neuralgia in terms of neuropathic pain mechanisms involving neuroinflammation, altered synaptic transmission, signal transduction, and neuronal plasticity. Cytokine dysregulation and microglial activation are linked to neuronal and glial injury, while TNF-alpha can increase excitatory signaling through NMDA receptors and reduce inhibitory GABA-A receptor activity, shifting the balance toward excitation.

Conditions that damage or disease the central or peripheral somatosensory nervous system increase risk. The grounding specifically identifies nerve compression, channelopathies, autoimmune disease, incision, and diabetic neuropathy as associated settings.

Management is described at the level of mechanism-based and drug-therapy approaches for neuropathic pain, with emphasis on improving analgesia through better diagnostic classification. The supplied abstracts also support use of pharmacologic strategies targeting neuropathic pain mechanisms and nonpharmacologic approaches such as acupuncture-electroacupuncture in persistent pain, but they do not provide a single unified standard regimen for neuralgia.